IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 222 filers reported holding IMMUNOGEN INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $218 | -99.9% | 11,554 | -77.6% | 0.03% | +12.5% |
Q3 2022 | $247,000 | +268.7% | 51,535 | +244.3% | 0.02% | +200.0% |
Q2 2022 | $67,000 | -70.7% | 14,970 | -68.8% | 0.01% | -70.4% |
Q1 2022 | $229,000 | +43.1% | 48,035 | +143.7% | 0.03% | +50.0% |
Q1 2021 | $160,000 | +128.6% | 19,709 | +44.1% | 0.02% | +63.6% |
Q4 2019 | $70,000 | +169.2% | 13,681 | +25.2% | 0.01% | +120.0% |
Q3 2019 | $26,000 | -89.4% | 10,929 | -53.3% | 0.01% | -86.5% |
Q1 2018 | $246,000 | +261.8% | 23,400 | +119.0% | 0.04% | +208.3% |
Q4 2017 | $68,000 | -82.9% | 10,684 | -79.4% | 0.01% | -81.2% |
Q3 2017 | $397,000 | +146.6% | 51,920 | +188.5% | 0.06% | -8.6% |
Q1 2015 | $161,000 | – | 17,997 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |